(Q35093080)

6 August 2017

title

New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada (English)

1 reference

6 August 2017

0 references

1 reference

Judith D Bentkover

1

1 reference

6 August 2017

Edward J Stewart

2

1 reference

6 August 2017

Andrew Ignaszewski

3

1 reference

6 August 2017

Serge Lepage

4

1 reference

6 August 2017

Peter Liu

5

1 reference

6 August 2017

Jill Cooper

6

1 reference

6 August 2017

publication date

1 March 2003

1 reference

International Journal of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

88

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

33-41

1 reference

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Cost effective management programme for heart failure reduces hospitalisation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Ventricular assist device programs: design and function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Cost effectiveness of artificial organ therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900378-9

7 January 2021

10.1016/S0167-5273(02)00378-9

Identifiers

DOI

1 reference

6 August 2017

1 reference